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Membrane topologyProteinsmediating the transport of solutes across the cellmembrane control the intracellular conditions inwhich
life can occur. Because of the particular arrangement of spanning a lipid bilayer and the many conformations
required for their function, transport proteins pose signiﬁcant obstacles for the investigation of their structure–
function relation. Crystallographic studies, if available, deﬁne the transmembrane segments in a “frozen” state
anddonot provide information on thedynamics of the extramembranous loops,which are similarly evolutionary
conserved and thus as functionally important as the other parts of the protein. The current review presents
biophysical methods that can shed light on the dynamics of transporters in the membrane. The techniques that
are presented in some detail are single-molecule recognition atomic force microscopy and tryptophan scanning,
which can report on the positioning of the loops and on conformational changes at the outer surface. Studies on a
variety of symporters are discussed, which use gradients of sodium or protons as energy source to translocate
(mainly organic) solutes against their concentration gradients into or out of the cells. Primarily, investigations of
the sodium–glucose cotransporter SGLT1 are used as examples for this biophysical approach to understand
transporter function.inne-Saffran.
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Transport proteins play an essential role in biology. As soon as the
ﬁrst unicellular organisms enwrapped in a cell membrane emerged, the
control of solute trafﬁc across the cell barrier became of utmost
importance. This importance is reﬂected in the fact that about 25% of the
genome is predicted to code for proteins involved in transmembrane
transport [1]. The transport of a solute can either be active, when it
occurs against an electrochemical gradient, or passive following the
gradient. In turn, active transport can be achieved by so-called primary
active transport where, as in the case of the various ATPases, chemical
energy is used directly to energize the translocation of ions. Secondary
active transport systems use the ion gradients established by the
primary active transport systems via cotransport (symport and
antiport) for the accumulation of other solutes.
One of these symport systems is the sodium-D-glucose cotranspor-
ter (SGLT) found as early as in Vibrio and essential for nutrient uptake in
mammals [2]. There it serves as the mechanism by which D-glucose is
taken up into the body in the small intestine; in the kidney twodifferent
SGLTs recover D-glucose ﬁltered in the glomerulus from the primary
urine and prevent loss of the carbohydrate [3]. Major breakthroughs in
the understanding of themechanisms of transport and in themolecular
basis of transport of SGLT are the expression cloning by the group of
Ernest Wright [4] and, most recently, the crystallization and the
structural analysis of the Vibrio transporter by Faham et al. [5].
Membrane transporters are peculiar in their function in that during
the translocation of a solute they undergo a cycle of conformational
changes. In the outside orientation in the case of the SGLT binding of
sodium followed by the binding of glucose occurs, then an occluded
state is postulated. This step is followed by a conformation where the
solute is nowaccessible from the cytoplasmic space, and sodiumand the
sugar are released into the cell. The transporter ﬁnally assumes the
outside orientation again. Recently, several transporters have been
crystallized and possible detailedmechanisms of cotransport have been
proposed [5–10].
Recently, Claxton et al. [11] identiﬁed ion/substrate-dependent
conformational changes in bacterial homolog of neurotransmitter:
sodium symporter LeuT by using site-directed spin labelling and electron
paramagnetic resonance. Their results outline the Na+-dependent
formation of a dynamic outward-facing intermediate that exposes the
primary substrate-binding site and the conformational changes that
occlude thisbindingsiteuponsubsequentbindingof the leucinesubstrate.
Furthermore, their studies demonstrate that the binding of the transport
inhibitors induce structural changes that distinguish the resulting
inhibited conformation from the Na+/leucine-bound state. Applying the
same techniqueon lactosepermease(LacY), Smirnovaet al. [12] identiﬁed
sugar-binding-induced outward-facing conformation of the symporter;
conformational cycle of ABC transporter MsbA [13] in liposome was also
identiﬁed using double electron–electron resonance spectroscopy.
Another widespread appraoch to identify functionally important
parts in membrane cotransporter proteins is the subsituted cysteine
accessibility method (SCAM) [14]. Frillingos et al. [15] have extensivelyused the SCAM technique to identify different aspects of Lac permease
cotransporter. SCAMcan be used to identify functionally important sites
as well as reveal and/or conﬁrm secondary structural details, including
the peri- or cytoplasmic orientation of acccessible sites. A functionally
important region in the putative third extracellular linker (ECL-3) of the
renal Na+/Pi cotransporter (NaPi-Iia) was probed using SCAM [16], and
results of this study provide a valuable structure–function insights into
cotransport meachnism. SCAM is also widely used for the identiﬁcation
of functional aspects of differnet membrane proteins, namely, cyclic
nucleotide-gated channel [17], acetylcholine receptor [18,19], Plasmo-
dium falciparum equilibrative nucleoside transporter 1 (PfENT1) [20],
and the serotonin transporter [21]. Using the Cys residue accessibility
toward MTS in the putative sugar translocation pathway of SGLT1 in
combination with electrophysiology and ﬂuorescence measurements,
Loo et al. [22,23] elegantly measured real-time conformational changes
and charge movements. Their ﬁnding provides strong support for an
alternating access mechanism for Na+-driven cotransporters. They also
successfully identiﬁed two different conformational states of transport-
er, Na+-bound state (CNa2), and Na+/sugar-bound state (CNa2S).
Electrophysiology is another importnat biophysical tool to eluci-
date dynamics of membrane transporters. By measuring the electro-
physiological properties of hSGLT1 in the cut-open oocyte technique,
Chen et al. [24] identiﬁed two time constants, tau 1 and tau 2, which
correspond to two steps in the conformational change of the free
carrier. Na+-binding/debinding modulates the slow time constant
(tau 1), and a voltage-independent slow conformational change of the
free carrier accounts for the observed plateau value of 10 ms. In an
electrophysiology study on rabbit Na+/glucose cotransporter 1,
Hazama et al. [25] have shown that SGLT1 exhibits a presteady-
state current after step changes in membrane voltage in the absence
of sugar. These currents reﬂect voltage-dependent processes involved
in cotransport and provide insight on the partial reactions of the
transport cycle. Simulations of a 6-state ordered kinetic model for
rabbit Na+/glucose cotransport indicate that charge movements are
due to Na+-binding/dissociation and a conformational change of the
empty cotransporter. In a recent electrophysiology study on rabbit
SGLT1 [26], Na+ and voltage dependence of transient SGLT1 kinetics
was reported. Using step changes in membrane potential, in the
absence of glucose but with 100 or 10 mM Na+, transient currents
were measured, corresponding to binding/debinding of Na+ and to
conformational changes of the protein.
There is evidence from other transporters, e.g., γ-aminobutyric acid
transporters and citrate/malate transporter CimH, showing that exposed
surface loops canact as a binding region for organic substrates [27] or can
form a reentrant pore-loop-like structure with the accessibility depend-
ing on the conformation of the transporter [28–30]. During recent years,
therefore, our group and others have concentrated on methods that are
able to report on the conformational changes of those areas not resolved
in the crystallography studies to determine their contribution to
transmembrane transport.
One of these methods is atomic force microscopy, which, in its basic
form, can resolve surface structures at an atomic level. Such
Fig. 1. AFM force distance cycle. Schematic representation of a force–distance cycle. The
tip was moved toward the cell surface (dotted line, 1–2) and subsequently retracted
(solid line) at a constant lateral position. During tip approach, the antibody forms a
complex with an antigen which leads to a force signal of distinct shape (3) during tip
retraction. The force increases until dissociation occurs (4) at an unbinding force (fu).
Reprinted with kind permission from Puntheeranurak et al. [49].
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into shape and presence of pores or transporters, and further modiﬁca-
tions of the method, reviewed elsewhere [31], revealed other important
aspects of membrane proteins. Our group concentrated on the use of
single-molecule recognitionAFM,which combines speciﬁcity of the signal
with the analysis of forces and dynamics [32]. Using this method, results
were obtained with regard to the membrane topology of transporter
subdomains and identiﬁcation of the functional role of subdomains on the
cell surface. The maximal resolution obtained at this level is an area
represented by an array of about 30 amino acids.
To increase the resolution to the level of single amino acids,
tryptophan ﬂuorescence and its changes during the transport cycle
were investigated. Here, themain breakthrough occurred when hSGLT1
could be expressed in Pichia pastoris and isolated in a pure form in
signiﬁcant amounts by Tyagi et al. [33]. Combined with the tryptophan
scanningmethod,where deﬁned areas of the transporter canbe labelled,
this allowed the location of substrate and inhibitor sites both within the
protein and with regard to the membrane lipids. In addition, this
method, alsodescribed inmoredetail in this review, proved successful in
determining at the molecular level the conformational changes that
occur when inhibitors bind to subdomains of the transporter. This
information is important because, currently, attempts are made to
develop compounds that inhibit reabsorption of sugar in the kidney as a
new approach to control blood sugar and thereby treat diabetes [34].
2. Single-molecule recognition atomic force microscopy
Atomic force microscopy (AFM) is one of the most powerful tools
in nanobiotechnology. It can resolve features and surface topography
of native biomolecules at subnanometer resolution [35]. AFM can be
used on any kind of surfaces; hence, the number of AFM applications
in life sciences, materials science, physical science, and industry has
exploded since it was invented in 1986 [36]. The popularity of AFM is
due to a number of reasons, such as easily achievable high resolution,
low cost, little sample preparation, three-dimensional information in
real space, in situ observations, ﬂuid imaging, temperature controls,
environmental controls, etc.
2.1. Imaging techniques
The principle and operation of AFMhave been described extensively
[36]. Brieﬂy, its principle is relatively simple. It works in away similar to
a stylus proﬁler. The primary difference is that in AFM, the probe forces
on the surface are much smaller than those in a stylus proﬁler. A soft
cantilever tip is brought in contact with a surface. The repulsive force
from the surface applied on the tip bends the cantilever upwards. The
amount of bending, measured by a laser spot reﬂected on a split photo
detector, can be used to calculate the force. By keeping the force
constant while scanning the tip across the surface, the vertical
movement of the tip follows the surface proﬁle and is recorded as the
three-dimensional surface topography. The resolution of this method
relies on the end radius of the cantilever tip; reducing the end radius to
1 nm achieves atomic-scale resolution on hard surfaces [37]. There are
several AFM imaging modes available for speciﬁc purposes. In general,
contact and dynamic modes (i.e., tapping mode, intermittent or
magnetic AC mode) have been widely used. They differ mainly in the
way of tip raster-scan over the surface. For soft biological samples, e.g.,
cells, tissues, proteins, lipid membranes, the dynamic mode is often
preferable to achieve high-resolution and nondestructive imaging.
2.2. Interaction force experiments
With the potential of AFM to image surface structures at the
molecular scale and to measure ultra-low (a few piconewtons) forces
at high lateral resolution, AFM also offers a unique opportunity to
detect molecular recognition between individual ligands and recep-tors at different experimental conditions [38,39]. Biochemical mod-
iﬁcation of the cantilever tips [40,41,42] has paved the way for
detecting ligand–membrane protein interactions at the single-
molecule level. This provides fundamental insights into molecular
dynamics of biological processes, e.g., the inter- and intramolecular
interactions of biomolecules, and protein unfolding.
The principle of this technique is illustrated as a scheme of AFM force
distance cycles in Fig. 1. The general strategy is to bind ligands to AFM
tips and to probe sample or specimens for receptors on the surface. The
ligands can be a speciﬁc antibody, a protein of interest, a substrate, or an
inhibitor. The receptor can be a protein immobilized on various surfaces
such as mica, glass, silicon, etc., or it can be a protein expressed on
membranes of living cells. In a force–distance cycle (Fig. 1), the tip
tagged with the ligand is ﬁrst approached towards the surface
whereupon a single receptor–ligand complex is formed based on the
speciﬁc ligand–receptor recognition.During subsequent retractionof the
tip fromthe surface, an increasing force is exertedon the ligand–receptor
connection until the interaction bonds break at a critical force
(unbinding force, fu, calculated by using Hook's law F=kΔx, where k is
the cantilever spring constant and Δx is the cantilever deﬂection). Such
experiments allow to estimate afﬁnity and rate constants and to deﬁne
structural data of the binding pocket. In addition, they can be used to
localize ligands andmembrane receptors on biological surfaces [43–45].
In this review, we will describe how AFM can be used to explore the
topology, conformational changes, and substrate–carrier interactions of
the cotransporter SGLT1 protein in living cells on a single-molecule level.
2.3. Generation of antibody/substrate/inhibitor-tagged cantilevers
In single-molecule recognition AFM, the binding of ligand molecules
(e.g., a speciﬁc antibody) to the AFM tip or to the surface is a critical step.
This requires a careful AFM tip sensor design, including a ﬁrm attachment
of the ligands to the tip surface at a low surface density. Moreover, the
attached ligands should have enough mobility to interact with comple-
mentary molecules. To fulﬁl such goal, many kinds of ligand tip
construction have been developed [46]. The recognition of ligands and
its cognatemolecule on the target surface is greatly facilitated by inserting
a long,ﬂexible poly (ethylene glycol) (PEG) chain between the tip and the
probemolecule. The PEG spacer has several distinct advantages: PEG itself
is a water-soluble, nontoxic, chemically and physically inert polymer, and
the ligand can freely move and rotate around the tip within a restricted
volume deﬁned by the length of the cross-linker.Moreover, the nonlinear
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interactions from nonspeciﬁc tip–sample adhesion. Cross linker can vary
in lengths. In our laboratory, we commonly used PEG linker of extended
lengths of 6 nm; however, we recently also developed a longer cross-
linker to probe deeper into transmembrane proteins.
To beable to reactwith the tip surface aswell as the ligands the cross-
linker is equipped with two different functional ends, i.e. one end
couples to the tip and another end couples to the ligand. The
heterobifunctional cross-linker widely used for protein (e.g., antibody)
coupling has an N-hydroxy-succinimidyl (NHS) residue on the one end,
which reacts to amines on the ethanolamine coated tip and a 2-
pyridyldithiopropionyl (PDP) or a vinyl sulfon (VS) residue on the other
end, which can covalently bind to thiols of ligands. This sulfur chemistry
is highly advantageous, since it is very reactive and renders site-directed
coupling possible. However, free thiols are hardly available on native
ligands and must, therefore, be generated, e.g., by modiﬁcation with
SATP [N-succinimidyl-3-(S-acetylthio) propionate]. Other linkerswidely
used forprotein coupling inour laboratory are thealdehyde-PEG800-NHS
and maleimide-PEG800-NHS linkers, which interact with free amino
groups of the peptide chains [41]. With these linkers, the need for
prederivatization of nonthiol proteins is eliminated.
For our transporter experiments, the AFM tips were initially
tagged with speciﬁc antibodies via PDP-PEG800-NHS linkers, however,
after the development of the aldehyde-PEG800-NHS linker this one
was used more frequently (Fig. 2A) [47,48]. In brief, AFM tips are ﬁrstFig. 2. Linkageof ligands to AFMtips. (A) Speciﬁc antibodieswere covalently coupled toAFM tips
(right). (B) Sugars were covalently linked to AFM tips via vinyl sulfon-PEG800-NHS (large end g
PEG800-NHS was used to couple phlorizin to the AFM tips. The NHS end of the PEG linkers werfunctionalized with ethanolamine by an overnight incubation with
ethanolamine hydrochloride solubilized in Me2SO. Then the alde-
hyde-PEG800-NHS linker is covalently bound to amino groups on the
tip surface. Next, the speciﬁc antibodies are coupled via the aldehyde
function to the PEG-conjugated AFM tips. The tips are ﬁnally rinsed in
the AFM working buffer and stored in the cold room. In glucose-
binding experiments, the free SH group of 1-thio-β-D-glucose was
coupled to the AFM tips via a VS-PEG-NHS linker or via newly
developed acrylamide-PEG800-NHS and acrylamide-PEG5000-NHS lin-
kers (Fig. 2B) [47,49]. The thio-glucose linked via a thio-glycosidic
bond at the C1 position generates the 1-thio-D-glucose tip. Altogether,
these methods use single-molecule tips, which contain a very low
surface density of ligands (about 400 molecules/μm2) on the tip
surface to allow separate detection of single molecular events.
3. Tryptophan ﬂuorescence
3.1. Intrinsic tryptophans
The aromatic amino acids tryptophan, tyrosine, and phenylalanine
contribute to the intrinsic ﬂuorescence of proteins. When all three
residues are present in a protein, pure emission from tryptophan can be
obtained only by photo selective excitation at wavelengths above
295 nm [50]. Although tyrosine and phenylalanine are natural ﬂuor-
ophores in proteins, tryptophan is themost extensively used amino acidvia a heterobifunctional PEGderivatives, PDP-PEG800-NHS (left) andaldehyde-PEG800-NHS
roup) and acrylamide-PEG800 (and PEG5000)-NHS (small end group). (C) The maleimide-
e covalently bound to amines on the functionalized tip surface.
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ﬂuorescent amino acids, observation of tyrosine and phenylalanine
ﬂuorescence is often complicated because of the interference by
tryptophan resonance energy transfer [50,51]. Tryptophan residues
serve as intrinsic, site-speciﬁc ﬂuorescent probes for protein structure
and dynamics [50] and are generally present at about 1 mol% in proteins
[51]. The low tryptophan content of proteins is a favourable feature,
which facilitates interpretation of ﬂuorescence data and reduces
complications due to intertryptophan interactions [52].
3.2. Tryptophan scanning
The well-documented sensitivity of tryptophan ﬂuorescence to
microenvironmental factors such as polarity makes tryptophan ﬂuores-
cence a valuable tool in studies of protein structure anddynamics [50,51].
Thus, it has been documented that the position of the wavelength
maximum of the ﬂuorescence is shifted to a higher wavelength in a very
hydrophilic environment and to a lower wavelength in more hydropho-
bic surroundings (see also Figs. 12 and 13). The presence of tryptophan
residues as intrinsic ﬂuorophores in most peptides and proteins makes
them an obvious choice for ﬂuorescence spectroscopic analysis.
Tryptophans can be selectively introduced at various positions of the
molecule (called tryptophan scanning). Thus, a peptide or protein can be
mutated to replace critical amino acids by a tryptophan residue. This
tryptophan then acts as a reporter group for any structural or
conformational changes in the protein [53,54].
3.3. Quenching by hydrophobic and hydrophilic quenchers
Fluorescencequenching is operationallydeﬁnedasa reduction in the
measured ﬂuorescence intensity when a ﬂuorophore interacts with
another molecule or group, called the quencher. After absorption of a
photon, and before emission of radiation, a ﬂuorescent molecule
remains in its excited state for a short period, usually referred to as
the excited state lifetime,which is typically innanoseconds. If there is an
interaction of a ﬂuorophore in the excited state with a quencher, the
excited ﬂuorophore may be deactivated before emission of light can
take place. The magnitude of quenching depends on the competition
between the ﬂuorescence process, the quenching process and other
processes that lead to the deactivation of the excited state and are
determined by their relative rates. The magnitude of quenching also
depends on the concentration of the quencher, which determines the
number of quencher molecules in close proximity to the ﬂuorophore.
Depending on the degree of intermolecular motion during the lifetime
of the excited state, there can be two major quenching mechanisms:
static and dynamic. Static quenching occurswhen the distance between
theﬂuorophore andquencher doesnot change during the lifetimeof the
excited state of the ﬂuorophore. A special case of dynamic quenching
occurs when the range of quenching interactions is sufﬁciently small so
that only collisions between ﬂuorophore and quencher result in
quenching of ﬂuorescence. This is called collisional quenching. The
rate for such quenching processes is then limited by diffusion; in cases
where quenching is efﬁcient, this rate is the diffusion-controlled
collision rate [50–52].
Hydrophobic compounds such as fatty acids, retinoids, or cholesteryl
oleate diminish the ﬂuorescence of some proteins. Analysis of the
ﬂuorescence data suggests that these proteins have a binding site for
hydrophobic ligands [55]. Similarly, 2,2,2- triﬂuoroethanol is a useful
hydrophobic quencher for proteins having predominantly tryptophan
emission [56,57]. Aswill be detailed below, sodium-dependentD-glucose
cotransport inhibitors that interact with SGLT1 via their hydrophobic
moieties [53,54,58].
Quenching measurements employing small hydrophilic molecules
such as potassium iodide (KI) and acrylamide (ACR) have been used
successfully to study the accessibility of ﬂuorescent groups in
membrane proteins [51,53,54,58,59]. If at least one tryptophan residueis involved in direct substrate-binding or located in a segment
undergoing domain transfer and/or conformational change, alterations
are expected in protein ﬂuorescence characteristics, i.e., emission
wavelength, quantum yield, and/or susceptibility to quenching. By
monitoring the intrinsic protein tryptophan emission and bymeasuring
the relative abilities of KI and acrylamide to quenchproteinﬂuorescence
in the presence of various ligands, we have now obtained further
evidence for apparent conformational or positional changes that occur
in this protein during D-glucose translocation or inhibitor binding [58].
Because the extent of ﬂuorescence quenching depends on the
accessibility of the ﬂuorophore for the quencher, it has been very well
utilized to explore the topology (surface or buried) of tryptophan
residues in soluble proteins and peptides [53,54,60]. Another major
application of ﬂuorescence quenching has been to analyse penetration
depths of membrane-bound proteins and peptides [61]. Membrane
penetration depth is an important parameter in the study of membrane
structure and organization. The depth of a group within a bilayer
provides important information on topography, orientation and folding
of membrane-bound proteins and peptides. In a typical quenching
experiment usingmodelmembranes, a series ofmolecules labelledwith
quenchers that occupy different depths in the bilayer are incorporated
into themembrane,which also contains the ﬂuorophore of interest. The
quenchers are often fatty acids or phospholipids with a quencher (spin
label groups or heavy atoms such as bromine) covalently attached to the
polar head group or to a speciﬁc fatty acyl carbon atom. This mode of
attachment gives the quencher a relativelywell-deﬁned depth provided
it does not loop back. In general, phospholipids labelled with quencher
groups serve as better probes for such depth studies than quencher-
labelled fatty acids for a number of reasons [62]. However, for studies
involving native membranes, labelled fatty acids are preferred due to
the relative ease of incorporation.
The quencher groups commonly used are dibromo or nitroxide
derivatives. The quenching interactions for membrane-bound ﬂuor-
ophores and quenchers are predominantly static in naturewith a typical
quenching range of 8–12 Å [62–64]. The amount of quenching is
determined from the ratio of ﬂuorescence in a sample containing the
quencher (deﬁned as F) to that in a sample in which the quencher is
omitted (deﬁned as F0). The pattern of variation of F/F0 as a function of
the depth of the quencher has been utilized to explore depths of
penetration of tryptophan residues and other extrinsic ﬂuorophores,
e.g., in the nicotinic acetylcholine receptor [65], the haemolytic peptide
melittin [66], cholesterol oxidase [67], the plant toxin ricin [68], the
calcium-dependent membrane bound annexins [69], ion channels [70],
and fusogenic peptides [71], signal sequence peptides [72], colicin [73],
translocation proteins [74], Omp A protein [75], hSGLT1 [58], and C-
terminal loop 13 of SGLT1 [76].
4. AFM studies of the binding domains under
physiological conditions
4.1. Antibody-tagged cantilever
4.1.1. Membrane topology of the transporter
Several approaches have been used previously to determine the
topology of the cotransporter SGLT1, for example computational
algorithms, scanning mutagenesis, proteomics, and immunostaining
methods [77–81]. For SGLT1 a model is proposed which contains 14
transmembraneα-helices and13surfacedomainsor loops connecting the
transmembrane segments (Fig. 3). However, the structural intramem-
brane topology of the SGLT1, especially of the large C-terminal loop
connecting TMD 13 and 14, is still a matter of controversy [77–81]. An
alternative way to probe the surface topology is to use AFM force
spectroscopy [82]. The advantages of this approach are that one can probe
unaltered cells, i.e. unﬁxed (living cells) under near-physiological
conditions in terms of ion composition of the intra- and extracellular
medium,membranepotential, andmembraneﬂuidity. It is also important
Fig. 3. Membrane topology of SGLT1. (A) Secondary structure proposed by Turk et al. [54]. The structure model shows 14 transmembrane helices with both the NH2 and COOH
termini facing the extracellular compartment. (B) Secondary structure modiﬁed according to the results obtained with the antibody-tagged AFM tips. Reprinted with kind
permission from Puntheeranurak et al. [48].
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addition of glycosylation sites or tags; the latter can inﬂuence the protein
orientation in the membrane. In addition, association of the transporter
with other proteins inside the membrane, the cytoskeleton, and/or the
cytoplasm is not likely to be disturbed. Thereby, three different antibodies
(named QIS30, PAN2-2, and PAN3-2) against the three large extramem-
branous subdomains of SGLT1, i.e. subdomain I (loop 6–7), subdomain II
(loop 8–9), and subdomain III (loop 13–14), respectively, were employed
in single-molecule force spectroscopy experiments. The antibodies were
separately coupled to AFM tips by using the heterobifunctional cross-
linker as mentioned above. Force–distance cycles were performed at a
ﬁxed lateral position above the living cells, as described in Fig. 1, with the
assistance of a CCD camera for the localization of the AFM cantilever on
isolated cells or cell monolayers. The sweep–amplitude of the force–
distance cycles was 1000 nm at a 1-Hz sweep rate. The typical speciﬁc
recognition events from all three antibody-tagged AFM tips are shown in
Figs. 4 and 5. Speciﬁcity of the recognition was conﬁrmed by blocking
experiments either by blocking the surface receptor with free antibodies
or by blocking the AFM tip with free antigens. To achieve statistical
signiﬁcance, up to 500–1000 force–distance cycles were performed for
each location on the surface of cells and up to four locations (different
cells)were investigated for each experimental condition. From the results
of these experiments, we could verify that subdomain I and subdomain II,
as postulated from other studies, are located on the outer membrane
surface of the transporter. In addition, we obtained evidence that at least
the latepart of subdomain III is also accessible fromtheextracellular space,
suggesting amodel for themembrane topology of the transport shown in
Fig. 3, which contains a reentrant loop [48]. These results corroboratestudies by the group from Gagnon et al. that have conﬁrmed an
extracellular orientation of the disputed loop 13–14 of SGLT1 using a
different approach [79]. Immunohistochemistry and trypsin digestion
analysis also support this ﬁnding [80,81 and Puntheeranurak et al.
unpublished]. If one assumes that during substrate translocationby SGLT1
conformational changes occur, transmembrane helix 14 as a dynamic
helical structure could alternate between inside-facing and outward-
facing states, as previously reported for the Escherichia coli β-glucoside
transporter BglF [83]. Thus, single-molecule AFM with antibody-tagged
tip is a powerful tool for investigating topology of transporter and other
membrane proteins.
4.1.2. Functional role of extracellular loops
Several studies of membrane transporters have proposed an
important role of extracellular loops in facilitating substrate-binding
and translocation [27–30]. For SGLT1 transporter, there are three large
extramembranous loops that could be the site where the ﬁrst
interaction with the substrate occurs. The interaction between
antibodies and their antigens is very sensitive to changes in the
conformation of the latter. This phenomenon can be used to probe for
conformational changes of subdomains during the catalytic transport
cycle. The interaction of the various domains of SGLT1 with antibody-
tagged cantilevers was therefore tested under conditions where the
carrier is supposed to assume different translocation-related states.
First the state was induced in which a sodium–transporter complex
is formed. Interestingly, as shown in Fig. 6, the presence of sodium did
not alter the binding probability of any of the antibodies- suggesting
onlyminor changes in the conformation of the three extracellular loops.
Fig. 4. Identiﬁcation of SGLT1 on intact cells. Recognition of SGLT1 on the surface of intact cells by an AFM tip carrying an epitope speciﬁc antibody (PAN3-2). (A) Force curve showing
speciﬁc interaction between the antibody and SGLT1 upon tip surface retraction. The speciﬁc interaction is blocked by injecting free PAN3-2 antibodies (0.3 μM) in the solution
(inset). (B) Quantitative comparison of binding probabilities of PAN3-2-coated tips on SGLT1 expressing CHO cells (G6D3) (gray) and control CHO cells (black) in the absence or
presence of free PAN3-2 in the medium. Values are mean±SEM, n=2000–4000, P<0.005 compared with levels in the control group (unblocked). (C) Probability density function
(PDF) giving the distribution of the unbinding force (fu) of PAN3-2 to SGLT1 (n=1000).
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carrier complex observed using other biophysical approaches [22] occur
inside the transporter and are not detectable in this part of the trans-
porter surface. A signiﬁcant change in the binding probability of the
antibody directed to subdomain II was, however, observed when theFig. 5. Recognition of extramembranous loops of SGLT1 on the surface of intact cells by
Quantitative comparison of binding probabilities of PAN3-2 (A), QIS30 (B), and PAN2-2 (C)
antibodies (3 μM) in the medium. Values are mean±SEM (standard error of the mean), n=
antibodies in solution, value from the ﬁrst bar). Reprinted with kind permission from Puntinteraction in the presence of the substrate D-glucose and sodium was
tested (Fig. 6C). This indicates that during the formation of the sodium–
glucose–carrier complex signiﬁcant changes in the conformation of the
transporter occur, which can be detected at the protein surface. Such
changes were also observed measuring the intrinsic tryptophanAFM tips tagged with epitope-speciﬁc antibodies (against subdomain I, II, and III).
antibodies, coupled to AFM tips to G6D3 cells in the absence or presence of free speciﬁc
2000–4000; ***P<0.005 compared with levels in the relevant controls (absence of free
heeranurak et al. [48].
Fig. 6. Effect of D-glucose andNa+ on the recognition of extramembranous loops of SGLT1
by antibodies. Effect of D-glucose on the binding probabilities of subdomain I (A, B),
subdomain II (C, D), and subdomain III (E, F) antibody-tagged AFM tips to the surface of
G6D3 cells in the presence of Na+ (left row) and in the absence of Na+ (right row). Values
aremean±SEM (n=1500–4000; **P<0.01 and ***P<0.005) comparedwith levels in the
relevant controls (absence of 10 mM D-glucose or 3 μM antibodies, value from the ﬁrst
bar). Reprinted with kind permission from Puntheeranurak et al. [48].
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tryptophan ﬂuorescence studies of the reconstituted transporter [84].
Additional studies involving site-directed mutagenesis of the cysteine
residues located in this subdomain showed that the conformation of this
loop critically inﬂuences the afﬁnity of the transporter for D-glucose
[48].
Furthermore, biochemical labelling studies and experiments testing
the accessibility of the cysteines in the three loops suggest a disulﬁde
bridge exists between loop 6–7 and loop 13–14. It is noteworthy in this
context that different isoforms of SGLT1 exhibit individual properties in
term of kinetics, substrate speciﬁcity, and inhibitor afﬁnity [85].
Therefore, minor differences in the functional structure of different
SGLT1 isoforms, particularly in the surface loops, might be expected.
Irrespective what the exact partners are, such an intramolecular
disulﬁde bridge would bring loop 6–7, loop 8–9, and loop 13–14 closer
together. Thereby a vestibule of the transporter consisting of the threeloops could be formed which contains the ﬁrst site of interaction of the
substrate with the transporter [48]. Biacore studies on the isolated loop
13 further support this assumption [86].
4.2. Substrate/inhibitor-tagged cantilever
4.2.1. Investigations on the initial sugar-binding site
Interactionof small ligandswithproteins is required for translocation
of the ligand itself, enzymatic reactions or regulation of the protein.
SGLT1 is one of the proteins that undergo a series of conformational
changes during the transport cycle [18–22]. Development of AFMand tip
chemistrymake it possible to couple small ligands such as 1-thio-glucose
to the AFM tip, allowing for the ﬁrst time to probe the glucose-binding
site on SGLT1 in its native membrane incorporated state [47,49]. In this
case, 1-thio-glucose-tagged AFM cantilevers (see above) were used to
study the initial sugar-binding site. The experimental procedure was
similar to the one employedwith antibody-tagged AFM tips. The sugar is
linked to the tip in such a way that the major recognition sites of the
molecule (C2, C3, and C4) remain unaltered. The results illustrated in
Fig. 7 shows that speciﬁc unbinding events of 1-thio-glucose to the
SGLT1 transporter can be detected. The speciﬁc binding events were
observed only in the presence of sodium and only on SGLT1-transfected
CHO cells. The speciﬁcity of the interaction could also be conﬁrmed by
blocking the sugar-binding site with the potent inhibitor of SGLT1,
phlorizin, (Fig. 7A) as well as blocking the transporter with a speciﬁc
antibody [43]. Furthermore, the probability of binding was the same as
that observed with the antibody-tagged cantilevers (see above). The
average unbinding force of about 50 pN was smaller than that obtained
with the antibodies (see Fig. 4), probably due to a lower afﬁnity of the
sugar to SGLT1. Since 1-thio-glucose is covalently attached to the
cantilever tip and due to the bulkiness of the p-vinylsulfonylbenzoyl
group present at the end of the linker (see above), it can be assumed that
the sugar is not translocated, and only the sitewhere theﬁrst interaction
of the sugarwith SGLT1occurs is investigated. This offered thepossibility
to investigate theproperties of this binding site inmore detail. First of all,
the binding site seems to be accessible only in the presence of sodium,
thus suggesting that it is functionally active only when sodium is bound
to the carrier. As a further characteristic, the substrate speciﬁcity of the
binding site was investigated by blocking experiments using a variety of
sugars. As expected, D-glucose (see Fig. 8) reduced the binding
probability of the sugar-tagged cantilever—the same held for trans-
ported sugars such as D-galactose,α-methyl-D-glucoside (AMG), and 6-
deoxy-D-glucose. L-glucose and 3-deoxy-D-glucose, sugars that are not
transported, did not interact with the binding site, suggesting that a D-
glucose conﬁguration andapresenceof anOH-groupat C3 is required for
the initial interaction with the carrier. Interestingly, 2-deoxy-D-glucose,
also a nontransported sugar, prevented the interaction between the 1-
thio-glucose-tagged cantilever and the carrier but inhibited only slightly
AMG uptake. These results might suggest an initial binding site that
represents a ﬁrst selectivity ﬁlter that selects sugars with regard to D-or
L-conformation and the presence or positioning of OH-groups at C1, C3,
C4, and C6 but not at C2. The rejection of 2-deoxy-D-glucose has to occur
later during a subsequent-binding/transport step. A similar discrepancy
between initial binding and translocation has been observed previously
in rat kidney proximal tubule. 2-Deoxy-D-glucose was shown to inhibit
binding of phlorizin to isolated brush border membrane vesicles, but no
transepithelial transport of the sugar was observed in microperfusion
studies [87,88]. This raises the question why 2-deoxy-D-glucose does
inhibit transport only slightly (if at all) but inhibits binding in the AFM
and phlorizin-binding studies. In a model where the two steps binding
and translocation are assumed to be sequential, equal inhibition of
bindingand transport should be observed. Apparently, in thepresence of
a large substituent at C1, suchas thevinylsulfongroup in theAFMstudies
or the two aromatic rings in phlorizin, the presence and positioning of
the OH-group at C2 seems to become irrelevant for the binding reaction,
thus both D-glucose and 2-deoxy-D-glucose act as inhibitors, based on
Fig. 7. Recognition of SGLT1 on the surface of intact cells by a 1-thio-glucose-tagged AFM tip. (A) The effect of phlorizin (0.5 mM) and the antibody PAN3-2 (3 μM) in the presence of
Na+ (KRH-NaCl) on the binding probabilities of 1-thio-glucose tip on G6D3 (gray) and CHO cells (black). (B) Probability density function (PDF) giving the distribution of the
unbinding force fu required to disrupt single glucose–receptor interaction (n=1000). (C) Binding probabilities of 1-thio-glucose-tagged tip to G6D3 cells in the presence of Na+
(gray) and in the absence of Na+ (sodium replaced by N-glucosamine) (blue), respectively. Values are mean±SEM, n=2000–4000. *P<0.05 and ***P<0.005 compared with levels
in the control group (unblocked).
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to conformational changes and sterical hindrances at the glucose
molecule itself or to similar events at the transporter. In the absence of
a large substituent (and as a free sugar) like in the AMG uptake studies,
rejection of 2-deoxy-D-glucose as a substrate probably occurs already at
theearly binding site, and thus, the subsequent transport is not inhibited.
Similar considerations seemnot to apply to theOH-group at C3, which is
further removed from the C1 position because 3-deoxy-D-glucose
inhibits neither binding nor transport to a signiﬁcant extent.
To reach the translocation site that is located deeper within the
transporter, other linkers such as acrylamide-PEG800-NHS and acryl-
amide-PEG5000-NHS were used to couple the sugar to the AFM tips.
These linkers are longer, and the acrylamide end group is less bulky and
smaller than the p-vinylsulfonylbenzoyl group at the end of the linker.
When scanning SGLT1-expressing cellswith AFM tips taggedwith these
linkers, speciﬁc binding events could be observed in a comparable
probability. The main difference between the various linkers is the
increase in unbinding force found for the long acrylamide linker that
probably arises from additional interactions of the sugar with
transmembrane parts of SGLT1 [32]. Therefore, such long cross-linker
might be promising candidates for studying the translocation pathways
of transport proteins.
4.2.2. Investigations on the inhibitor-binding site
Inhibitors of SGLT have been recently become the focus of
pharmaceutical and therapeutic interest in an attempt to ﬁnd
substances that block glucose absorption in the intestine or glucose
reabsorption in the kidney [34]. Thus, a detailed understanding of the
interaction between inhibitors and the transporter is desirable. A
“classic” inhibitor of the transporter is phlorizin, a β-glycoside derived
from the bark of apple tree roots. It is known to inhibit sodium-
dependent sugar transport with a high afﬁnity, the Ki being about one
thousand fold lower than the Km for glucose translocation [89].
For this purpose, amino-phlorizinwas synthesized by amodiﬁcation
of a previously published method [Neundlinger et al., unpublished].
Amino-phlorizin was coupled to the AFM tip via C3 of the aromatic ring
B extended with a 6-mercaptohexanoic acid spacer to PEG1300-
maleimide (see Fig. 2C). This coupling chemistry facilitated an ideal
orientation for binding to the transporter as the major binding sites of
phlorizin, the 2-,3-,4-, and 6-hydroxyl group of the pyranose ring and
the 4´-OH and 6´-OH of the adjacent aromatic ring A are free to interact
with SGLT1 [90]. We observed distinct recognition events between
amino phlorizin-tagged cantilevers and SGLT1 expressed on the plasmamembrane of living cells. Speciﬁcity of the interactions could be
conﬁrmed by masking the phlorizin-binding site with free phlorizin.
Additionally, no signiﬁcant-bindingeventswereobservedwhenparental
CHO cells not expressing SGLT1 were probed [Neundlinger et al.,
unpublished]. These results support previous observations by Wielert-
Badt et al. [91], where iodo-aceto-phlorizin had been used to probe the
interaction between phlorizin and SGLT1 on isolated brush border
membrane vesicles by AFM force spectroscopy. Thus, the phlorizin-
binding epitopes on SGLT1 were accessible in both experiments.
Dynamic force spectroscopy experiments in which the rate of
scanning is systematically varied generate force spectra from which
additional information on the size of bindingpockets and afﬁnities canbe
derived. The energy length scale of the binding pocket of amino phlorizin
seemed to be larger than that of glucose; indicating that the energy
landscape of the phlorizin-binding pocket is larger than that of glucose
[Neundlinger et al., unpublished]. These results are in good agreement
with previous studies where it was shown that phlorizin binds to SGLT1
via its sugar moiety as well as its aglucone (phloretin) moiety. It was
supposed that ﬁrst the sugarmoiety of phlorizin binds to the transporter
followed by the binding of the aglucone moiety to a hydrophobic part of
the protein resulting in a larger binding pocket of phlorizin. Additionally,
conformational changes induced by phlorizin were predicted to be
different to the reordering induced by glucose [92–94]. The amino acids
involved in glucose-binding and those involved additionally in binding of
the aglucone can also be visualized in the tryptophan scanning
experiments of the isolated carrier (see below).
The size of the binding sites has been estimated from modelling of
various inhibitors into a pharmacophore model to be in the order of
17×10×7 Å [90]. Thus about 170 Å2, a rather small portion of the total
transporter surface of about 2000 Å2, are involved in the binding of
phlorizin. Furthermore, a lower dissociation rate of phlorizin compared to
glucose was found as expected from the higher afﬁnity of phlorizin to
SGLT1 which has been observed previously [Neundlinger et al.,
unpublished].
To identify the subdomain involved in phlorizin-binding, AFM
studies with phlorizin-tagged cantilever were combined with the use
of subdomain-speciﬁc antibodies. Antibodies against subdomain III
(aa 606–630) were demonstrated to reduce the binding probability,
suggesting that the approach of phlorizin to its binding site was
hindered in the presence of the antibody. The role of this segment of
the transporter and the conformational changes occurring during the
formation of the binding site phlorizin complex will be discussed
below.
Fig. 8. Inhibition of initial D-glucose binding by various sugars. Binding probabilities of 1-thio-glucose tip and the effect of 2-deoxy-D-glucose (A, black-dotted bar), 6-deoxy-D-glucose
(B, crossed bar), D-glucose (C, vertical-lined bar), D-galactose (D, horizontal-lined bar), AMG (E, bricked bar), D-xylose (F, chess bar), L-glucose (G, diagonal bar), and 3-deoxy-D-glucose
(white-dotted bar) (10mM each). Values are mean±SEM, n=2000–4000. 2do-Dglc, 2-deoxy-D-glucose; 6do-Dglc, 6-deoxy-D-glucose; D-glc, D-glucose; D-gal, D-galactose; AMG, α-
methylglucoside;D-xyl,D-xylose; L-glc, L-glucose;3do-Dglc, 3-deoxy-D-glucose; Phlz, phlorizin. *P<0.05, **P<0.01, and***P<0.005 comparedwith levels in therelevantcontrols (absence
of sugars or phlorizin in solution, value from the ﬁrst bar). Reprinted with kind permission from Puntheeranurak et al. [49].
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Fig. 9.NBSmodiﬁcation of hSGLT1 Trp residues in solution (■), and after reconstitution
in proteoliposomes (●). 1 μMhSGLT1 in solution or in reconstituted in proteoliposomes
in the lipid–protein ratio of 200:1 was subjected to NBS modiﬁcation using 5-, 10-, 20-,
30-, 40-, 50-, 75-, and 100-fold molar excess of NBS over the transporter using a 2 mM
stock solution of NBS in buffer. The decrease in emission intensity at 338 nm was
monitored after 5 min of NBS addition, excitation wavelength used was 295 nm. A plot
of the percent residual ﬂuorescence at equilibrium (5 min) as a function of molar ratio
of NBS/hSGLT1 is shown. Reprinted with kind permission from Kumar et al. [84].
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5.1. Positioning of tryptophans in the intact carrier in solution and
reconstituted in liposomes
The success in hSGLT1 expression and puriﬁcation from P. pastoris
[33] has opened a new avenue for different biophysical studies. Puriﬁed
hSGLT1 in proteoliposomes exhibits substrate speciﬁcity in the
following order: α-MDG>D-Glc≈D-Gal>>Man>All>L-Glc. The ap-
parent Km values for various sugars and the stereospeciﬁcity of
recombinanthSGLT1mirror those determined for hSGLT1 [95]. Catalytic
turnover of hSGLT1 is 6 s−1, which is in good agreement with that
obtained in previous studies [95] and other Na+-dependent transpor-
ters (e.g., the Na+/glucose transporter of Vibrio parahaemolyticus [96],
and Na+/proline transporter of Escherichia coli [97]).
In the past 5 years, our group and others have utilized tryptophan-
quenching techniques to explore unique features of transporters
[33,58,84,98–101]. The location of the emission maximum of the
combinedﬂuorescence of the 14 tryptophans present in hSGLT1 suggests
that, in detergent-containing solutions, the majority of tryptophans are
located in a hydrophobic environment. This assumption is supported by
the low accessibility of tryptophans to hydrophilic quenchers. Similar
ﬁndings have been reported for other isolated membrane proteins such
as the Na+/galactose cotransporter of V. parahaemolyticus [99], lactose
permease of E. coli [100], and P-glycoprotein multidrug transport
transporter [101]. The same conclusion was reached in KI, acrylamide,
and TCE-quenching studies of hSGLT1 inproteoliposomes,wheremost of
tryptophan residues remain inaccessible to hydrophilic quenchers.
However, in the presence of D-glucose, a tryptophan residue (or
conceivably, fractional populations of several tryptophans) becomes
located in a region which is more accessible to water due to
conformational changes. This conformation is quite different from the
one assumed by the carrier in the presence of phlorizin. Here a
conformation prevails which is less compact, representing probably a
more ﬂexible state, which might prepare the transporter to execute the
transmembrane translocation of the sugar and sodium ions [22].
Kumar et al. [84] also measured accessibility of the hSGLT1
tryptophans in solution and after reconstitution into liposomes by
chemical modiﬁcation using n-bromosuccinimide (NBS) as an oxidant
(see Fig. 9). In the reconstituted state, even at a 50-fold molar excess of
NBS, 75% of ﬂuorescencewas still observable, indicating thatmost of the
tryptophan residues are inaccessible to chemical modiﬁcation from the
outside of the membrane. This result is in good agreement with the low
degree of quenching exerted by the collisional quenchers. Quenching of
hSGLT1 tryptophan ﬂuorescence by NBS in solution shows a different
pattern. In solution, approximately 35% of tryptophan residues in the
transporter are deeply buried within the hydrophobic core of protein
itself, since 65% of tryptophans are accessible for NBS oxidation
compared to only 25% in the reconstituted form. These results clearly
indicate that in a reconstituted form, about 40% of tryptophan residues
are inaccessible for NBS modiﬁcation due to their close contact with
phospholipids and 35% tryptophan residues are buried deep inside the
hydrophobic core of protein.
5.2. The sugar translocation and inhibitor-binding sites
One tryptophan scanning study of hSGLT1 from our group provides
quite valuable information about the substrate recognition and
inhibitor-binding sites in the cotransporter [54]. In this study, four
single tryptophan residues (Q457W, T460W, F602W, and F609W)were
separately introduced into a functional hSGLT1 mutant devoid of
tryptophan residues (see Fig. 10). Trp457 and Trp460 mutants of
hSGLT1 exhibit emission maxima at 343 and 340 nm, respectively,
showing that the indole ring lies in a moderately hydrophilic
environment. In mutants Trp457 and Trp460 D-glucose and phlorizin,
but not the aglucone phloretin, quenched tryptophan ﬂuorescence tothe same extent (Figs. 10A and B). Both provide also protection against
acrylamide, potassium iodide (KI), and trichloroethanol (TCE) quench-
ing [58]. The parallax method (see details in hydrophobic quenching
section) revealed an interfacial location for Gln457 at 10.8 Å and a
deeper localization of Thr460 at 7.4 Å from the center of the bilayer;
similar locations for these residues have been suggested in previous
studies [77,78]. These results suggest that Gln457 and Thr460 are
located in an area that forms part of the binding sites for D-glucose and
for the sugar moiety of phlorizin (for a comparison with the vSGLT1
crystal structure, see Section 7).
The emission maxima for Trp602 and Trp609 mutants are in the
range of 346–350 nm, which is typical for a very hydrophilic
environment. Mutants Trp602 and Trp609 located in loop 13 exhibits
in the presence of phlorizin a very strong quenching in ﬂuorescence
with 4–5 nm red shift in emission maxima (Figs. 10C and D). Both
mutants also show protection against collisional quenchers in the
presence of phlorizin and phloretin. These results indicate that Phe602
and Phe609 provide binding sites for the aglucone part of phlorizin
(phloretin). Binding afﬁnity of different ligands with hSGLT1 and its
different single tryptophan mutants as determined by change in
intrinsic tryptophan ﬂuorescence exactly matched those determined
by sugar uptake assay [58], indicating that the ﬂuorescence changes
occur at the sugar translocation site and not at the site of initial sugar
binding identiﬁed above.
These results suggest that, in the native carrier, amino acids critically
involved in sugar translocation reside in a hydrophilic access pathway
extending 5–7 Å into the membrane. It is interesting to note that, from
the crystal structure of various sodium-dependent transporters, a
similar location of the sugar translocation site can be predicted [5]
(see Fig. 11). To the same site, the sugar moiety of phlorizin is binding-
extending about 5 Å into the transporter. This distance compares
favourably with the depth of the binding pocket predicted from the
pharmacophore studies [90]. The agluconemoiety of phlorizin interacts
in addition stronglywith Trp located in loop 13 at positions602 and 609.
This extramembranous loop had already been identiﬁed inmutagenesis
studies as a region critically involved in phlorizin binding [102].
Fig. 10. Changes of ﬂuorescence induced by D-glucose and phlorizin at different domains of hSGLT1 labelled with Trp. Transporters containing only one Trp at a deﬁned position were
isolated and incorporated into liposomes. Corrected emission spectrum of (A) W457hSGLT1, (B) W460hSGLT1, (C) W602hSGLT1, and (D) W609hSGLT1. For each experiment, 5 μM
protein reconstituted into proteoliposomes in the ratio of 150:1 was incubated in the absence (solid line), presence of 10 mM D-glucose (dotted line), or presence of 100 μMphlorizin
(dashed line). The excitation wavelength was 295 nm. The results shown are typical of ≈20 independent experiments. Reprinted with kind permission from Tyagi et al. [58].
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phlorizin-tagged cantilevers. Thus, the Trp ﬂuorescence studies have
added important information on the location of the sugar and phlorizin-
binding site.6. Biophysical studies on isolated subdomains of the carrier
6.1. Tryptophanﬂuorescence scanning studies on isolated loop 13 in solution
In view of the strong evidence that loop 13 is involved in the binding
of phlorizin to the transporter, it became of interest to study the
conformational changes induced by the inhibitor inmore detail. For this
purpose, several truncated loop 13 mutants were produced which
contained one tryptophan at a deﬁned position; therefore, the peptide
could be scanned at every 10th amino acid position. Then the
ﬂuorescence spectrum and its changes by phlorizin as well as changes
in accessibility of the tryptophan to hydrophilic quenchers were
investigated [53].
Results of these experiments are shown in Fig. 12, which make it
obvious that at each tryptophan position different movements of the
peptide occur. From the shifts in themaximum, the decrease or increase
in ﬂuorescence and the changes in accessibility to hydrophilic
quenchers the detailed model shown in Fig. 13 for the interaction at amolecular resolution could be obtained—deﬁning acceptor as well as
donor molecules of phlorizin and the peptide [53].
6.2. Biacore studies on isolated loop 13 reconstituted in lipid bilayers
Surface plasmon resonance (SPR) analysis is now widely used to
study antibody–antigen, protein–protein, DNA–protein, DNA–DNA,
and receptor–ligand interactions [103,104]. SPR analysis has been
utilized to study binding of peptides to phospholipid membranes and
to derive information regarding the membrane selectivity and
structure–function relationship of antimicrobial peptides through
binding afﬁnity data [105].
We have also taken advantage of this technique to immobilize C-
terminal loop 13 (aa 541–638) of SGLT1 on phospholipid bilayers and to
demonstrate preservation of the native conformation and reactivity of
this peptide [86]. Six histidine tags were introduced at both sides of the
loop. The bilayers hydrophobic part as well as the space between the
bottom sheet of the bilayer and the covalently bound dextran–matrix of
the hydrophilic sensor chip appeared to facilitate incorporation of the
whole loop 13 into the membrane [86]. This analysis conﬁrmed the
interaction of the loop with phlorizin, D-glucose, and L-glucose as well
as the point of attachment of loop 13 via hydrophobic amino acids
between aa 625 and 631,which, bymeasuring tryptophanﬂuorescence,
had been shown previously to enter the lipid bilayer [77].
Fig. 11. Hypothetical scheme of major interaction sites between D-glucose and phlorizin with subdomains of hSGLT1. D-Glucose or the sugar moiety of phlorizin interact with
residues Gln457and Thr460 present in transmembrane helix XI probably by the same hydrogen bonds; the aromatic ring A of the aglucone of phlorizin interacts with Phe609/
Phe602, and ring B makes contact with Phe602/Phe609; both are present in the extramembranous loop 13 of hSGLT1. Reprinted with kind permission from Tyagi et al. [58].
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studies-based results in light of the available structural information
of different transporters
The recently elucidated crystal structure of the solute sodium
symporter family member sodium–galactose transporter (vSGLT) from
V. parahaemolyticus [5] is a major advance toward understanding the
structure–function relationship in this important class of transporters.
The overall architecture has a maximal height and diameter of ~75 Å
and~55 Å (Fig. 14). There are14 transmembranehelical segments (TM1
to TM14) with both N- and C-termini exposed to the periplasm. Most
interestingly, vSGLT shared a common core structure of 10 transmem-
brane helices (TM1–10) with different gene families and symporters
like LeuT, Mhp1, and BetP [8]. Although there is no sequence similarity
between the internal repeat, they have a high degree of structural
conservation permitting superimposition with each other.
The vSGLT structure is composed of a central group of seven helices
(TM2, TM3, TM4, TM7, TM8, TM9, and TM11) that contribute side chain
interactions for ligand selectivity, along with seven supporting helices
that stabilize these central helices. A striking feature is the two
discontinuous TM helices, TM2 and the symmetrically related TM7
helices, in the center of the protomer. In TM2, there is a break in the
hydrogen-bonding pattern, dividing it into a roughly equivalent
intracellular (TM2I) and extracellular (TM2E) components. In TM7,
the helix is disrupted at residues F266, N267, Q268, andY269, dividing it
into a shorter intracellular (TM7I) and a larger extracellular (TM7E)
segment. This structural feature may have particular functional
importance as previously reported for several other cotransporters
[106–108].Topology of vSGLT and other symporters based on the available
structural information show a seven helices inverted repeat core
structure [8–10]. However, our topology model for SGLT1 based on
AFM studies presented in this review is in stark contrast with inverted
repeat idea. Possible explanation of this discrepancy might be the
prokaryotic nature of vSGLT versus eukaryotic SGLT1 (rabbit) or the use
of different experimental techniques, vSGLT in a frozen state versus
SGLT1 expressed in G6D3 cells in a dynamic and fully functional form.
However, it is also possible that our topology results represent the
different conformational states of the transporter during a translocation
cycle as previously observed in tryptophan ﬂuorescence studies on
hSGLT1 [33] and in electrophysiology studies on SGLT1 in Xenopus
oocytes [22]. Presences of reentrant loop were also reported for the
topologymodels for rat brain glutamate transporter [28,30] and citrate/
malate transporter of Bacillus subtilis [29].
Faham et al. [5] determined that galactose is bound about half way
across themembrane bilayer by speciﬁc side chain interactions from the
central helices TM2E, TM3, TM7E, TM8, and TM11. The galactose-
binding site is sandwiched between hydrophobic residues that form
intracellular and extracellular gates. On the intracellular side, Y263 from
the discontinuous helix TM7E stacks with the pyranose ring, a common
feature seen in all sugar-binding structures to date [6,109]. This primary
interaction, along with the ﬂanking residues Y262, and W264,
establishes a gate that prevents exit of sugar to the large hydrophilic
cavity contiguouswith the intracellular compartment. The extracellular
gate is formed by a triad of hydrophobic residues (M73, Y87, and F424).
Directly above the hydrophobic residues, there are substantial interac-
tions between TM11, TM3, TM2E, and TM7E with the loops from TM2–
TM3, TM8–TM9, and TM10–TM11. For the veriﬁcation of structural data
Fig. 12. Effect of phlorizin on ﬂuorescence emission spectra of single Trp mutants of loop 13 in solution. The dotted lines show the corrected spectra, and the solid lines represent the
effect of 100 μMphlorizin on the intrinsic ﬂuorescence of each Trp mutant. The protein samples include (A) Q581W, (B) E591W, (C) R601W, (D) D611W, (E) E621W, and (F) L630W.
Reprinted with kind permission from Raja et al. [53].
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acids identiﬁed as potential substrate-binding partner, Faham et al. [5]
mutated those amino acids into alanine and measured galactose
transport in proteoliposomes. The Q69A, E88A, N260A, K294A, and
Q428A mutations did not show Na+-dependent galactose transport. In
contrast, the S91A mutant behaved normally, which suggests that this
aminoacid is not essential for transporter function (S91 is not conserved
across different species). Mutants of the corresponding sugar-binding
sites in SGLT1 (K321A, Q457R, Q457C, and Q457W) provide strong
support for the arguments that these residues also play an important
role in the mammalian transporter [26,58,110]. In our tryptophan
scanning studies [58],we alsoobserved that theQ457Wmutant shows adrastic change in the sugar transport properties and has lower afﬁnities
towards different substrates. Parallax method revealed a similar
location for this residue as observed for the correspondingQ428 residue
in vSGLT crystal structure. However, in our tryptophan scanning studies,
we identiﬁed also residue T460 as a probable amino acid involved in
sugar-binding/transport and inhibitor binding, which is in contrast to
the vSGLT crystal structure. Probable reasons for discrepancy might be
that this residue involved in sugar-binding/transport only transiently or
in an indirect fashion. So far, no crystallographic information is available
for SGLT1 in a phlorizin-bound state, so our tryptophan scanning results
for the phlorizin-binding sites cannot be compared (yet)with structural
data.
Fig. 13. A two-dimensional model of the interaction between loop 13 and phlorizin. (A) Two-dimensional model of truncated loop 13 of rabbit SGLT1 (amino acids 564–638). Left
panel: arrangement of amino acids in the absence of phlorizin. α-Helical areas are based on a computer program; the arrangement of random coil takes into account the
hydrophobicity of the tryptophan environment as predicted from the ﬂuorescence maxima. Right panel: yellow represents the Trp mutations; green represents the presumed
phlorizin-binding region; the red arrow indicates the proposed position of phlorizin in the binding region; and the blue arc highlights the main area of conformational changes. The
exposure of the region around position 611 to a more hydrophilic environment is derived from the strong red shift in the tryptophan ﬂuorescence maxima. (B) Three-dimensional
conformation of phlorizin according to NMR studies by Wielert-Badt et al. [90]. The arrows show the interactions of aromatic ring A with the binding region. Reprinted with kind
permission from Raja et al. [53].
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Mhp1, and BetP [8]. For LeuT, vSGLT, and Mhp1, the sodium-binding
site is located at the intersection of TM1 and TM8~8 Å away from the
substrate-binding site. There appears to be a conserved coordination
pattern made by carbonyl oxygens in the unwound segment of TM1
and hydroxyl groups from serine and/or threonine residues in TM8
[111]. Functional evidence for sodium-binding site in vSGLT is
provided by the ﬁnding that mutation of S365 abolishes transport [5].
8. Synopsis
The aim of the studies presented above was to learn more about the
role and dynamics of extramembranous loops of a transporter in
substrate-binding and inhibitor interaction. For SGLT1, the following
picture emerges. Extra membranous loops 6–7, 8–9, and the late part of
loop 13–14 face the extracellular space. They have a tertiary structure
deﬁned by helical sections within the loops (in particular, loop 13) and
the connections of the loops via disulﬁde linkages. This “vestibule”
exhibits sufﬁcient stability to act as the primary selectivity ﬁlter of the
transporter. The site is normally occluded; access becomes only possible
when sodium is bound to the carrier. The formation of the sodium–
carrier complex causes conformational changes, which open the access
to the sugar translocation site, buried about 5 Å deep in the protein. This
might involve iris-likemovements of scaffolding transmembranehelices
as described for the betaine transporter [112]. The sugar can subse-
quentlydiffuse into thehydrophilic pocket andbinds to the translocation
site. The binding also alters the conformation of the vestibule—potentially to aid in the vectorial movement of the transportate through
the carrier. The ensuing steps—transition from the cis- conformation into
the trans-conformation which includes establishing of hydrophobic
diffusion barriers at both sides of the transportate and subsequent
opening of a hydrophilic pocket toward the cytoplasmic space—are well
described in the crystallographic studies [5].
The extramembranous loops play also an important role in the
binding of inhibitors to the transporter. For glycosidic inhibitors with
aromatic or aliphatic aglucones they provide stereoselective recogni-
tion sites for the aglucones. The binding induces elaborate conforma-
tional changes in loop 13 which are transferred to the conformation of
the transmembrane helices promoting a very condensed state of the
transporter in which no translocation can occur.
Biophysical techniques thus provide tools to study the processes
occurring at the surface of a transport protein, be it the outer surface by
allowing determination of the topology, functional role, and conforma-
tional changes of extramembranous segments; be it by localizing and
characterising processes taking place at the inner surfaces, the selectivity
ﬁlters and the translocation sites of a transporter. Also, the interactions at
the lipid–protein interfaces between the transporter and the membrane
lipids can be investigated. These techniques allow us to investigate the
transporter protein from a different perspective, which can strengthen
the knowledge obtained by other means. Thus, biophysical methods
present an important complementary approach in our aim to understand
the structure–function relationship of those proteins which control the
passage of solutes across the membranes of the cells, thereby providing
the intracellular environment wherein life can exist.
Fig. 14. Structure of vSGLT. (A) Topology. The structure is colored as a rainbow from the N terminus (red) to the C terminus (purple). The blue and red trapeziums represent the
inverted topology of TM2 to TM6 and TM7 to TM11. The gray hexagon with red trim represents the galactose. Residues involved in sugar recognition, gate residues, and a proposed
sodium binding site are shown in cyan, gray, and yellow circles. (B) Structure viewed in the membrane plane. The coloring format and numbering of α-helices is same as in panel A.
(C) Structure viewed from the intracellular side. Reprinted with kind permission from Faham et al. [5].
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